PRKDC and cholangiocarcinoma: Most importantly, NU7026 treatment was able to rescue the increased number of γ-H2ax nuclear foci induced by the CK2 inhibitor, CX4945 (Fig 4), suggesting that CK2 and DNA-PK in the setting of CCA act as antagonists in the modulation of DNA repair machinery.